Eric Schweiger, M.D. is a dermatologist in private practice in Manhattan. He practices cosmetic and general dermatology, with a particular focus on laser and light based treatments, the treatment of adults with acne, and aesthetic enhancements with dermal fillers. Dr. Schweiger has participated in numerous research studies and is a clinical laser trainer, teaching other physicians how to use lasers. Recently, Dr. Schweiger published the first case report using Restylane to treat a patient with cleft-lip....Read More
Eric Schweiger, M.D. is a dermatologist in private practice in Manhattan. He practices cosmetic and general dermatology, with a particular focus on laser and light based treatments, the treatment of adults with acne, and aesthetic enhancements with dermal fillers. Dr. Schweiger has participated in numerous research studies and is a clinical laser trainer, teaching other physicians how to use lasers. Recently, Dr. Schweiger published the first case report using Restylane to treat a patient with cleft-lip. Dr. Schweiger is a Clinical Instructor of Dermatology at Mount Sinai. He received his M.D. degree from the Albert Einstein College of Medicine, where he was elected into the prestigious Alpha Omega Alpha Honor Society. Dr. Schweiger completed his internship at NYU Medical Center and his dermatology residency at the University of Kansas.
Medical School - Albert Einstein College of Medicine of Yeshiva University
New York University Medical Center, Internship in Internal Medicine
University of Kansas, Residency in Dermatology
Medical School - Albert Einstein College of Medicine of Yeshiva University
New York University Medical Center, Internship in Internal Medicine
University of Kansas, Residency in Dermatology
Board Certifications
American Board of Dermatology
American Board of Dermatology
Awards and Publications
Alpha Omega Alpha Honor Medical Society
Schweiger ES. Dalbavancin: a viewpoint by Eric S. Schweiger. Drugs 2008; 68(5):649-51.
Schweiger ES, Riddle CC, Aires DJ. Successful Treatment with Injected Hyaluronic acid in a Patient...Read More
Alpha Omega Alpha Honor Medical Society
Schweiger ES. Dalbavancin: a viewpoint by Eric S. Schweiger. Drugs 2008; 68(5):649-51.
Schweiger ES, Riddle CC, Aires DJ. Successful Treatment with Injected Hyaluronic acid in a Patient with Lip Asymmetry after Surgical Correction of Cleft-lip. Dermatologic Surgery 2008 May 34 (5) 117-119.
Schweiger ES, Riddle CC, Aires DJ. 20% Aminolevulinic Acid Photodynamic Therapy to Treat Hidradenitis Suppurativa: Description and Interim Results of a Pilot Clinical Study. Journal of the American Academy of Dermatology 2008 February (Suppl.), 58(2): P428 [Abstract].
Amin K, Riddle CC, Aires DJ, Schweiger ES. Common and alternate oral antibiotic therapies for acne vulgaris: A Review. Journal of Drugs in Dermatology 2007 September (6) 9: 873-880.
Schweiger ES, Riddle CC, Wernli B, Tonkovic-Capin V. Comparison of Poly-L-Lactic Acid and Calcium Hydroxylapatite for the Treatment of Human Immunodeficiency Virus-Associated Lipoatrophy. Cosmetic Dermatology 2007 May; 20(5): 304-312.
Riddle CC, Amin K, Schweiger ES. Review of Azithromycin for the Treatment of Acne Vulgaris. Cosmetic Dermatology 2007 May; 20(5): 299-302.
Tonkovic-Capin M, Riddle CC, Schweiger ES, Mason S, Tonkovic-Capin V. Brief Discussion: Medicolegal Aspects of Consent and Checklists for Common Cosmetic Procedures. Cosmetic Dermatology 2007 May; 20(5): 291-294.
Hurwitz DJ, Schweiger ES. Tips for teaching cosmetic dermatology to residents. Cosmetic Dermatology 2007 May; 20(5): 276-277.
Schweiger E, Spann CT, Weinberg JM, and Ross B. A Case of Desmoplastic Trichilemmoma of the Lip Treated with Mohs Surgery. Dermatologic Surgery 2004 Jul; 30(7):1062-4.
Garzon MC and Schweiger E. Cutis Marmorata Telangiectatica Congenita. Seminars in Cutaneous Medicine and Surgery 2004 June; 23(2):99-106.
Garzon MC and Schweiger E. Cutis Marmorata Telangiectatica Congenita. Seminars in Cutaneous Medicine and Surgery 2004 June; 23(2):99-106.
Schweiger ES, Scheinfeld NS, Tishler HR, and Weinberg JM. Linezolid and Quinupristin/Dalfopristin: Novel antibiotics for gram-positive infections of the skin. Journal of Drugs in Dermatology 2003 Aug; 2(4): 378-83.
Gamper C, van Eyndhoven WG, Schweiger E, Mossbacher M, Koo B, Lederman S. TRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexes. Journal of Molecular Immunology 2000 Jan-Feb; 37(1-2): 73-84.
